Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Fusion Pharmaceuticals Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +3 vs. Q1 2023
- Shares held
- 50.3M
- +4.68M (+10.3%) vs. Q1 2023
- Total value
- $235.1M
- +$63.1M (+36.7%) vs. Q1 2023
- New holders
- 5
- 10 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 2 | $9 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 30 | $140 | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 100 | $467 | 0.00% | +100 | New |
| Signaturefd, LLC | 300 | $1.40K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 700 | $3.23K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,401 | $6.00K | 0.00% | +942+205.2% | Added |
| Royal Bank of Canada | 1,839 | $9.00K | 0.00% | −364−16.5% | Reduced |
| Bank of America Corp | 2,325 | $10.9K | 0.00% | +2,325 | New |
| Dorsey Wright & Associates | 4,889 | $22.9K | 0.01% | +4,889 | New |
| BlackRock Inc. | 8,253 | $38.5K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 14,800 | $69.1K | 0.00% | +1,700+13.0% | Added |
| Forefront Analytics, LLC | 20,075 | $93.8K | 0.05% | +20,075 | New |
| Geode Capital Management, LLC | 30,374 | $142.2K | 0.00% | +5,238+20.8% | Added |
| Two Sigma Investments, LP | 31,154 | $145.5K | 0.00% | −13,673−30.5% | Reduced |
| Leonteq Securities AG | 35,000 | $163.8K | 0.02% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 43,394 | $203.1K | 0.01% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 57,297 | $267.6K | 0.04% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 65,400 | $305.4K | 0.00% | +29,500+82.2% | Added |
| UBS Group AG | 93,960 | $438.8K | 0.00% | +4,174+4.6% | Added |
| Sofinnova Investments, Inc. | 117,099 | $546.9K | 0.04% | 00.0% | Unchanged |
| Morgan Stanley | 137,611 | $642.6K | 0.00% | +19,376+16.4% | Added |
| Sio Capital Management, LLC | 246,036 | $1.15M | 0.41% | 00.0% | Unchanged |
| UBS Oconnor LLC | 274,568 | $1.28M | 0.03% | +32,542+13.4% | Added |
| Point72 Asset Management, L.P. | 328,868 | $1.54M | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 334,577 | $1.56M | 0.00% | −69,211−17.1% | Reduced |
| Ghost Tree Capital, LLC | 412,699 | $1.93M | 0.70% | +62,699+17.9% | Added |
| Eagle Health Investments LP | 680,370 | $3.18M | 0.59% | +680,370 | New |
| 1832 Asset Management L.P. | 734,321 | $3.43M | 0.01% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,329,258 | $6.21M | 1.33% | +45,721+3.6% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $7.29M | 2.40% | 00.0% | Unchanged |
| Artal Group S.A. | 1,725,000 | $8.06M | 0.26% | −250,000−12.7% | Reduced |
| TPG GP A, LLC | 2,551,794 | $11.9M | 0.17% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 2,751,395 | $12.8M | 0.37% | −8,541−0.3% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 2,823,000 | $13.2M | 0.28% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,947,809 | $13.8M | 3.60% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,122,770 | $14.6M | 0.28% | 00.0% | Unchanged |
| Canada Pension Plan Investment Board | 3,116,966 | $14.6M | 0.02% | 00.0% | Unchanged |
| Johnson & Johnson | 3,670,516 | $17.1M | 5.32% | 00.0% | Unchanged |
| FMR LLC | 4,681,457 | $21.9M | 0.00% | 00.0% | Unchanged |
| Avidity Partners Management LP | 5,700,000 | $26.6M | 0.93% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 10,633,789 | $49.8M | 0.12% | +4,784,689+81.8% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −659,992−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,084−100.0% | Sold out |